Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company that achieved regulatory approval in the European Union (EU) and the United Kingdom (UK) for the first authorized use of an ...
Resubmission of the ONS-5010 BLA targeted for Q1 CY2025; Initial commercial launches in Germany and the UK planned to commence in Q2 CY2025; ...
Scottish Medicines Consortium approves Libtayo as second-line treatment for advanced cervical cancer
Regeneron UK Limited today announced that the Scottish Medicines Consortium (SMC) has accepted Libtayo® (cemiplimab) for use on the National Health Service as a second-line monotherapy treatment for ...
The impact on Stake is immediate and has operational repercussions managed by TGP Europe Limited, which oversees the site as ...
The Global Vial Adaptors for Reconstitution Drug Market is poised for substantial growth, reflecting strong financial ...
The global remote patient monitoring market, valued at US$24.39 billion in 2023, is forecasted to grow at a robust CAGR of 12 ...
Before You Start, and After You Finish" training has been added to ResearchAndMarkets.com's offering.This course will teach how to establish a roadmap for conducting recalls. The knowledge you gain ...
Many consumer devices undergo the FDA clearance process, such as LED masks and fitness trackers that have features like ...
Bitpanda has received approval from the Financial Conduct Authority to offer more than 500 crypto assets in the United ...
Newronika, the developer of groundbreaking adaptive deep brain stimulation technology, is proud to announce the receipt of an ...
ROME (Reuters) - EssilorLuxottica said on Monday it received a green light from the U.S. Food and Drug Administration (FDA) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback